Karly Hamulyák

9.5k total citations
143 papers, 6.6k citations indexed

About

Karly Hamulyák is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Karly Hamulyák has authored 143 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Hematology, 44 papers in Cardiology and Cardiovascular Medicine and 42 papers in Internal Medicine. Recurrent topics in Karly Hamulyák's work include Blood Coagulation and Thrombosis Mechanisms (70 papers), Venous Thromboembolism Diagnosis and Management (42 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (21 papers). Karly Hamulyák is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (70 papers), Venous Thromboembolism Diagnosis and Management (42 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (21 papers). Karly Hamulyák collaborates with scholars based in Netherlands, United States and United Kingdom. Karly Hamulyák's co-authors include Saskia Middeldorp, Martin H. Prins, Cees Vermeer, Hugo Ten Cate, Harry R. Büller, Henri M.H. Spronk, Jan van der Meer, René van Oerle, Jan Rosing and Leon J. Schurgers and has published in prestigious journals such as New England Journal of Medicine, Circulation and Blood.

In The Last Decade

Karly Hamulyák

142 papers receiving 6.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karly Hamulyák Netherlands 47 3.5k 2.4k 2.3k 844 824 143 6.6k
Giovanni Di Minno Italy 54 4.1k 1.2× 1.5k 0.6× 2.5k 1.1× 221 0.3× 1.4k 1.8× 323 9.4k
Anne‐Mette Hvas Denmark 44 1.7k 0.5× 1.2k 0.5× 2.0k 0.9× 204 0.2× 1.2k 1.5× 306 6.3k
Yvonne Stirling United Kingdom 34 2.2k 0.6× 910 0.4× 1.8k 0.8× 458 0.5× 1.1k 1.3× 64 7.3k
Matteo Nicola Dario Di Minno Italy 49 1.9k 0.6× 1.4k 0.6× 1.7k 0.7× 174 0.2× 1.4k 1.7× 274 8.2k
Lilian Tengborn Sweden 37 2.7k 0.8× 798 0.3× 1.1k 0.5× 124 0.1× 756 0.9× 108 5.4k
Wolfgang Speiser Austria 32 1.5k 0.4× 1.1k 0.5× 1.1k 0.5× 112 0.1× 548 0.7× 90 3.6k
F. Haverkate Netherlands 32 1.8k 0.5× 558 0.2× 1.1k 0.5× 152 0.2× 770 0.9× 94 4.7k
Viviane Nicaud France 47 821 0.2× 283 0.1× 1.9k 0.8× 192 0.2× 1.3k 1.5× 111 5.7k
Rainer B. Zotz Germany 24 1.1k 0.3× 1.5k 0.6× 1.5k 0.6× 59 0.1× 626 0.8× 78 3.3k
Paulette Mehta United States 37 985 0.3× 352 0.1× 1.6k 0.7× 117 0.1× 698 0.8× 182 4.7k

Countries citing papers authored by Karly Hamulyák

Since Specialization
Citations

This map shows the geographic impact of Karly Hamulyák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karly Hamulyák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karly Hamulyák more than expected).

Fields of papers citing papers by Karly Hamulyák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karly Hamulyák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karly Hamulyák. The network helps show where Karly Hamulyák may publish in the future.

Co-authorship network of co-authors of Karly Hamulyák

This figure shows the co-authorship network connecting the top 25 collaborators of Karly Hamulyák. A scholar is included among the top collaborators of Karly Hamulyák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karly Hamulyák. Karly Hamulyák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cosemans, Judith M.E.M., Saskia E.M. Schols, Lucia Stefanini, et al.. (2010). Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow. Blood. 117(2). 651–660. 55 indexed citations
2.
Rennenberg, Roger, Bernard J. van Varik, Leon J. Schurgers, et al.. (2010). Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood. 115(24). 5121–5123. 104 indexed citations
3.
Kaandorp, S. P., Mariëtte Goddijn, Joris van der Post, et al.. (2010). Aspirin Plus Heparin or Aspirin Alone in Women With Recurrent Miscarriage. Obstetrical & Gynecological Survey. 65(10). 621–622. 253 indexed citations
4.
Borissoff, Julian Ilcheff, Sarah T.B.G. Loubele, Peter Leenders, et al.. (2010). Abstract 19565: Genetically Imposed Hypocoagulability Inhibits Atherogenesis and Promotes Plaque Stability. Circulation. 122. 120001–120001. 1 indexed citations
5.
Cate‐Hoek, Arina J. ten, Hugo Ten Cate, Jan H.M. Tordoir, Karly Hamulyák, & Martin H. Prins. (2010). Individually tailored duration of elastic compression therapy in relation to incidence of the postthrombotic syndrome. Journal of Vascular Surgery. 52(1). 132–138. 39 indexed citations
6.
Coppens, Michiel, Nic J.G.M. Veeger, V J J Bom, et al.. (2008). Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels. Thrombosis and Haemostasis. 100(7). 38–44. 20 indexed citations
7.
Schols, Saskia E.M., Marion A.H. Feijge, Marcus D. Lancé, et al.. (2008). Effects of plasma dilution on tissue factor–induced thrombin generation and thromboelastography: partly compensating role of platelets. Transfusion. 48(11). 2384–2394. 44 indexed citations
8.
Coppens, Michiel, Nienke Folkeringa, Margreet Teune, et al.. (2007). Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations. Journal of Thrombosis and Haemostasis. 5(7). 1444–1448. 27 indexed citations
9.
Sommeijer, Dirkje W., René van Oerle, Karly Hamulyák, et al.. (2005). Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with Type 2 diabetes. Journal of Thrombosis and Haemostasis. 4(3). 574–580. 27 indexed citations
10.
Hackeng, C. M., Marc M.H. Hermans, P.H.M. van der Kuy, et al.. (2004). The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients. Journal of Nephrology. 17(1). 107–111. 16 indexed citations
11.
Schins, Annique, Karly Hamulyák, Simon Scharpé, et al.. (2004). Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. Life Sciences. 76(6). 637–650. 72 indexed citations
12.
Braam, Lavienja A. J. L. M., et al.. (2004). Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thrombosis and Haemostasis. 91(2). 373–380. 154 indexed citations
13.
Libourel, Eduard J., Saskia Middeldorp, Karly Hamulyák, et al.. (2004). Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. Journal of Thrombosis and Haemostasis. 3(1). 79–84. 128 indexed citations
14.
Nap, Annemiek, Karly Hamulyák, René van Oerle, et al.. (2003). Performance of a novel test to quantify activated protein C resistance in women with a history of pre-eclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology. 113(1). 26–30. 2 indexed citations
15.
Middeldorp, Saskia, Eduard J. Libourel, Karly Hamulyák, Jan van der Meer, & H.R. Büller. (2001). The risk of pregnancy‐related venous thromboembolism in women who are homozygous for factor V Leiden. British Journal of Haematology. 113(2). 553–555. 60 indexed citations
16.
Meinardi, Johan R., Saskia Middeldorp, Pieter‐Jan de Kam, et al.. (2001). Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis. Blood Coagulation & Fibrinolysis. 12(8). 713–720. 22 indexed citations
17.
Knapen, Marjo H.J., et al.. (2000). Effect of Oral Anticoagulant Treatment on Markers for Calcium and Bone Metabolism. Pathophysiology of Haemostasis and Thrombosis. 30(6). 290–297. 19 indexed citations
18.
Oerle, René van, et al.. (1997). The Clinical Application of a New Specific Functional Assay To Detect the Factor VLeidenMutation Associated With Activated Protein C Resistance. American Journal of Clinical Pathology. 107(5). 521–526. 10 indexed citations
19.
Hemker, H.C., Karly Hamulyák, & H. Kessels. (1994). Hemostasis and thrombosis. Laboratory Medicine. 236–253. 15 indexed citations
20.
Haard, P.M.M. van, et al.. (1990). Vitamin K1 levels and K1-dependent coagulation factors II and X in preterm and small-for-date neonates. European Journal of Pediatrics. 149(9). 640–644. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026